What is the price of domestic Midostaurin?

Midostaurin (Midostaurin) is a broad-spectrum, multi-target tyrosine kinase inhibitor commonly used to treat certain types of blood cancers. It is an oral drug that is a targeted therapy designed to interfere with the growth and spread of leukemia and other blood diseases.

Currently Midostaurin is not available in China, so patients cannot purchase it domestically. Midostaurin abroad is divided into original drugs and generic drugs. The cheaper original version is the Indian version, which costs more than 10,000 yuan. Others include Turkish and European original drugs, which cost tens of thousands to hundreds of thousands, which are relatively expensive. Generic drugs are mainly Indian generic drugs, which cost about several thousand yuan per box. They are much cheaper than the original drug, and the drug ingredients are basically the same as the original drug.

Midostaurin is most commonly used to treat patients with acute myeloid leukemia (AML), especially those who carry mutations in FLT3 (FMS-like tyrosine kinase3 ). FLT3mutations are one of the most common mutations in AML and are often associated with disease progression and relapse. Midostaurin's mechanism of action includes inhibiting FLT3 enzyme activity, slowing or stopping the proliferation of malignant cells, thereby prolonging the survival of patients.

In addition, midostaurin is used to treat systemic mastocytosis (SM), a rare bone marrow mast cell disorder that is often associated with cutaneous and systemic symptoms. It is also used to treat a type of non-Hodgkin's lymphoma called lymphocytic leukemia/Lymphoma-Associated Kinase (Lymphoma-Associated Kinase,LAK) mutation.

Midostaurin side effects may include nausea, vomiting, diarrhea, fatigue, and skin reactions. While using this drug, doctors typically monitor patients' blood cell counts and other biochemical parameters to ensure safety and efficacy.